×
×
homepage logo
LOGIN
SUBSCRIBE

Shaheen marks fourteenth anniversary of the Affordable Care Act, celebrates record-breaking enrollment in New Hampshire

By Staff | Mar 23, 2024

U.S. Sen. Jeanne Shaheen

WASHINGTON – U.S. Sen. Jeanne Shaheen (D-NH) issued the following statement ahead of the fourteenth anniversary of the landmark Affordable Care Act:

“In the 14 years since President Obama signed the Affordable Care Act into law, thousands of Granite Staters have found coverage on the ACA Marketplace, including a record-breaking 65,000 enrollees this year. I’m proud of how far we’ve come, but there’s more work to do to make health care more affordable, such as lowering the cost of insulin to $35 a month for more Americans and continuing to reduce prescription drug costs. Health care is a right, not a privilege–I won’t stop fighting to make sure it’s available and affordable for more families in the Granite State and across the country.”

Shaheen has long fought to lower health costs for families in New Hampshire, including leading the change that made the most significant improvement to the ACA in a decade. Shaheen also successfully secured premium tax credit enhancement provisions from her legislation, the Improving Health Insurance Affordability Act, in the American Rescue Plan and the Inflation Reduction Act. Those provisions led to record Marketplace enrollment in 2023.

As a co-chair of the Senate Diabetes Caucus, Shaheen has also led action in the U.S. Senate to advance priorities that will reduce the cost of insulin, invest in treatment and prioritize diabetes research. Alongside Senator Susan Collins (R-ME) – also co-chair of the U.S. Senate Diabetes Caucus – Shaheen introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act to lower the drug’s cost for more Americans. Shaheen and Collins also recently penned a joint op-ed about the importance of lowering the cost of insulin. Shaheen has consistently held insulin manufacturers, insurers and pharmacy benefit managers accountable for the skyrocketing cost of life-saving insulin.

Newsletter

Join thousands already receiving our daily newsletter.

Interests
Are you a paying subscriber to the newspaper? *